GRAL
GRAIL, Inc.
Key Financials
Net Income
$-408351000
↑ 79.9%
Operating Income
$-562163000
↑ 74.3%
Revenue
$147.2M
↑ 17.2%
EPS (Diluted)
$-11.11
↑ 82.5%
Cash & Equivalents
$249.7M
↑ 16.6%
Shareholders' Equity
$2.6B
↑ 3.0%
Total Assets
$2.9B
↓ 2.1%
Total Liabilities
$344.2M
↓ 28.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GRAL |
| Company Name | GRAIL, Inc. |
| CIK | 1699031 |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (833) 694-2553 |